Eliem Therapeutics, Inc. (ELYM)

NASDAQ: ELYM · IEX Real-Time Price · USD
3.43
-0.03 (-0.87%)
May 20, 2022 4:00 PM EDT - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Selling, General & Admin
12.352.430.68
Research & Development
23.329.344.02
Other Operating Expenses
09.162.75
Operating Expenses
35.6720.937.45
Operating Income
-35.67-20.93-7.45
Other Expense / Income
11.81-0.26-0.9
Pretax Income
-47.48-20.67-6.55
Net Income
-47.48-20.67-6.55
Preferred Dividends
4.552.290.84
Net Income Common
-52.03-22.95-7.39
Shares Outstanding (Basic)
1222
Shares Outstanding (Diluted)
1222
Shares Change
460.40%31.72%-
EPS (Basic)
-4.24-10.49-4.45
EPS (Diluted)
-4.24-10.49-4.45
Free Cash Flow Per Share
-2.94-6.44-3.02
EBITDA
-47.48-20.67-6.55
EBIT
-47.48-20.67-6.55
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).